Clinical trial Recruiting at 1 site Observational Ages 18 and up

Using spleen size to help detect gastroesophageal varices in compensated cirrhosis

Official title: The Value of Spleen Thickness and Spleen Diameter for Gastroesophageal Varices Diagnosis in Compensated Cirrhosis

Run by Fifth Affiliated Hospital, Sun Yat-Sen University · NCT07920744 · Data updated 2026-11-12

This study tests whether ultrasound measurements of spleen size can help identify esophageal varices in adults with compensated cirrhosis, compared with the standard endoscopy test.

More Liver Cirrhosis trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment364 (estimated)
SponsorFifth Affiliated Hospital, Sun Yat-Sen University
Academic / other
Locations1 site (Zhuhai, Guangdong)
StatusRecruiting
StartedOctober 28, 2026
Main results expectedOctober 28, 2026
Study endsNovember 11, 2026
Registry record updatedNovember 6, 2026
Trial IDNCT07920744 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with compensated cirrhosis who have undergone both abdominal ultrasound and endoscopy within a six-month window.

Probably not a fit

Patients with decompensated cirrhosis, other liver or digestive system cancers, recent major treatments, or conditions that invalidate spleen and portal measurements may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a retrospective cross-sectional study that compares non-invasive ultrasound measurements of spleen thickness and spleen diameter to the invasive endoscopy results for detecting gastroesophageal varices and high-risk varices in patients with compensated cirrhosis. Researchers collected demographic, etiologic, and laboratory data along with imaging and endoscopy results to evaluate diagnostic performance. The analysis focuses on how well spleen size correlates with variceal presence and severity, potentially offering a non-invasive screening option. The study leverages data from patient records reviewed by senior infectious diseases and ultrasound physicians, with strict inclusion and exclusion criteria to define a stable compensated cirrhosis population.

Why it matters

Potential benefit: If successful, spleen measurements could provide a non-invasive screening option to identify patients who may need endoscopy.

How similar studies have gone: Previous work has explored non-invasive imaging markers for variceal risk, with mixed results, making this approach exploratory but promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥18 years;
2. compensated cirrhosis;

Exclusion Criteria:

1. history of hepatic decompensation, such as ascites, EVB, and hepatic encephalopathy;
2. non-cirrhotic portal hypertension;
3. digestive system malignancies such as hepatocellular carcinoma, pancreatic carcinoma, or other malignant tumors infiltrating the digestive system;
4. acute liver disease, or serum total bilirubin ≥ 100 μmol/L;
5. history of splenectomy;
6. acute or chronic portal vein thrombosis;
7. pregnancy;
8. concomitant HIV infection;
9. prior TIPS, endoscopic variceal ligation (EVL), or endoscopic injection sclerotherapy (EIS);
10. receipt of non-selective beta-blockers (NSBBs) or diuretics within 3 months before EGD or abdominal ultrasonography;
11. persistent drug abuse other than alcohol;
12. an interval of more than 6 months between abdominal ultrasonography and EGD, or the absence of results from either examination.

Where it's running

  • the Fifth Affiliated Hospital, Sun Yat-sen University
    Zhuhai, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.